Announcement I Posted: June 11, 2018
RFA: CBC Accelerator Award
▸ Announcing next round of applications
CBC Accelerator Award is a milestone-driven award program (up to $100,000 for 1st year) focused on translational research toward therapeutics or associated biomarkers and diagnostics.
Application dates: January 14-18, 2019
Announcement I Posted: August 29, 2018
RFA: CBC Catalyst Award
▸ CBC invites new applications
Catalysts are one-time incentive awards (up to $250,000), focused on basic biological/ biomedical research with transformative potential, made to teams with principals and other strong representation from at least two of the CBC institutions.
Application dates: February 11-15, 2019
Announcement I Posted: December 7, 2018
- Tuesday, April 9, 2019; 9:00 AM – 5:00 PM
- Wednesday, April 10, 2019; 9:00 AM – 1:00 PM
Instructor: Bryan H. Norman, PhD
(Retired from Eli Lilly and Company)
Announcement I Posted: December 12, 2018
17th Annual CBC Symposium (2019)
▸ CBC Future Science – AI, Genomics, and Bioethics
Location: UChicago Campus
More information coming up soon!
Announcement I Posted: December 5, 2018
POSITION OPEN: CBC Executive Assistant
The CBC has opened a search for the CBC Executive Assistant, who will provide specialized, complex, and confidential support to the Executive Director. The perfect candidate is a high functioning administrative professional with the ability to manage multiple priorities using discretion, diplomacy, and exemplary judgment. The Executive Assistant independently handles confidential and time sensitive information, prepares routine and advanced correspondence and manages the complex calendar of the Executive Director of the Chicago Biomedical Consortium. Event planning and coordination for CBC-sponsored events required.
Applications will be accepted through Friday, January 18, 2019.
Newsletter I Dec. 21, 2018
2018 has been a great year for the CBC and we have much to be thankful for. Here are some highlights we are happy to share with you!
News I Dec. 14, 2018
Standing room only at the CBC Accelerator Award Information Session at Northwestern.
News I Dec. 7, 2018
Fireside Chat with Constellation Pharmaceuticals CEO, Jigar Raythatha, Concludes CBCAN Programming for 2018. Hosted by CBC Executive Director, Jim Audia.
Posted: December 3, 2018
The NIA funded Alzheimer’s Clinical Trial Consortia (ACTC) soliciting proposals from investigators for consideration into larger clinical trials.
The ACTC is led by Dr. Paul Aisen ( USC), Dr. Reisa Sperling ( Harvard), Dr. Ron Petersen (Mayo), and Dr. Laurie Ryan from NIA. Projects that are developed as part of ACTC may be either NIA funded entirely, or funded as public-private partnerships. All phases of clinical trials are being considered as studies in this Consortium.
Posted: August 8, 2018
New, Updated and Expanded Services provided by the University of Chicago Genomics Facility
The University of Chicago Genomics Facility has:
Posted: August 1, 2018 (Updated Oct. 5, 2018)
New Opportunities for the CBC Community
Northwestern’s NSF-Simons Center for Quantitative Biology has a few opportunities for researchers in quantitative biology.
Posted: December 21, 2018
Save the date: Friday, February 8, 2019
Sponsor: UIC College of Pharmacy
▸ College of Pharmacy Research Day
Abstract submission deadline: Tuesday, January 15, 2019.
Posted: December 19, 2018
INVOForward Seeking Teams Interested in Commercializing Therapeutics
INVOForward is a mentorship program designed to help Northwestern teams accelerate biomedical commercialization, such as therapeutics, medical devices, and Health IT. It is designed to increase entrepreneurship by helping potential or current biomedical entrepreneurship teams focus on the customer discovery process and relevant commercialization ecosystem and terminologies. Through their discovery, the teams test and identify their market fit and assess the level of impact of their business proposition. INVOForward is modeled after, and will expand upon programs like the NIH I-Corps and University of Michigan’s Fast Forward Medical Innovation.
▸ Learn more